Gene · 55
Papers3,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Macrophages as a Therapeutic Target in Metastatic Prostate Cancer: A Way to Overcome Immunotherapy Resistance? | Cancers (Basel) | 2022 | 35053602 | PubTator, text mining | PubMed |
| Combination therapy for mCRPC with immune checkpoint inhibitors, ADT and vaccine: A mathematical model. | PLoS One | 2022 | 35015785 | PubTator, text mining | PubMed |
| Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states. | Nat Commun | 2022 | 35013146 | PubTator, text mining | PubMed |
| Immunotherapy for prostate cancer: Requirements for a successful regime transfer. | Investig Clin Urol | 2022 | 34983117 | PubTator, text mining | PubMed |
| Multi-omics of the expression and clinical outcomes of TMPRSS2 in human various cancers: A potential therapeutic target for COVID-19. | J Cell Mol Med | 2022 | 34951103 | PubTator, text mining | PubMed |
| 5-Alpha reductase inhibitors induce a prostate luminal to club cell transition in human benign prostatic hyperplasia. | J Pathol | 2022 | 34928497 | PubTator, text mining | PubMed |
| Chronic stress inhibits testosterone synthesis in Leydig cells through mitochondrial damage via Atp5a1. | J Cell Mol Med | 2022 | 34894202 | PubTator, text mining | PubMed |
| Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: a decade of research. | Br J Cancer | 2022 | 34811504 | PubTator, text mining | PubMed |
| Beyond liquid biopsy: Toward non-invasive assays for distanced cancer diagnostics in pandemics. | Biosens Bioelectron | 2022 | 34688113 | PubTator, text mining | PubMed |
| Loss of Endothelial TSPAN12 Promotes Fibrostenotic Eosinophilic Esophagitis via Endothelial Cell-Fibroblast Crosstalk. | Gastroenterology | 2022 | 34687736 | PubTator, text mining | PubMed |
| Evolving cancer-niche interactions and therapeutic targets during bone metastasis. | Nat Rev Cancer | 2022 | 34611349 | PubTator, text mining | PubMed |
| Inhibition of human lung cancer cells by anti-p21Ras scFv mediated by the activatable cell-penetrating peptide. | Anticancer Drugs | 2022 | 34338241 | PubTator, text mining | PubMed |
| Analysis of Circulating Immune Biomarkers by Race in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Sipuleucel-T. | J Natl Cancer Inst | 2022 | 34302463 | PubTator, text mining | PubMed |
| Safety and preliminary immunogenicity of JNJ-64041809, a live-attenuated, double-deleted Listeria monocytogenes-based immunotherapy, in metastatic castration-resistant prostate cancer. | Prostate Cancer Prostatic Dis | 2022 | 34257408 | PubTator, text mining | PubMed |
| Cancer neoantigens as potential targets for immunotherapy. | Clin Exp Metastasis | 2022 | 33950415 | PubTator, text mining | PubMed |
| Videos of Sipuleucel-T Programmed T Cells Lysing Cells That Express Prostate Cancer Target Antigens. | J Natl Cancer Inst | 2022 | 33630063 | PubTator, text mining | PubMed |
| Adamantinomatous craniopharyngioma associated with a compromised blood-brain barrier: patient series. | J Neurosurg Case Lessons | 2021 | 35854837 | PubTator, text mining | PubMed |
| In silico epitope prediction analyses highlight the potential for distracting antigen immunodominance with allogeneic cancer vaccines. | Cancer Res Commun | 2021 | 35611186 | PubTator, text mining | PubMed |
| The fabrication of TiO2-supported clinoptilolite via F- contained hydrothermal etching and a resultant highly energetic {001} facet for the enhancement of its photocatalytic activity. | RSC Adv | 2021 | 35480182 | PubTator, text mining | PubMed |
| Proteomic Analysis of the Alterations in Follicular Fluid Proteins During Oocyte Maturation in Humans. | Front Endocrinol (Lausanne) | 2021 | 35185790 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55/papers?page=21